Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Erasca, Inc. | ERAS | 1.57M | $28.69M |
Relmada Therapeutics, Inc. | RLMD | 1.46M | $10.1M |
Tango Therapeutics, Inc. | TNGX | 1.22M | $38.23M |
Biohaven Ltd. | BHVN | 1.06M | $15.84M |
Aura Biosciences, Inc. | AURA | 714.28K | $5.07M |
Tyra Biosciences, Inc. | TYRA | 632.75K | $20.21M |
First Tracks Biotherapeutics Inc | TRAX | 622.72K | $12.53M |
Mineralys Therapeutics, Inc. | MLYS | 602.69K | $16.26M |
C4 Therapeutics, Inc. | CCCC | 523.65K | $2.45M |
BioAge Labs Inc. | BIOA | 464.17K | $11.38M |
Amylyx Pharmaceuticals, Inc. | AMLX | 384.3K | $6.9M |
Solid Biosciences Inc. | SLDB | 358.78K | $3.58M |
Roivant Sciences Ltd. | ROIV | 348.41K | $12.33M |
Enliven Therapeutics, Inc. | ELVN | 346.91K | $17.61M |
EyePoint Pharmaceuticals, Inc. | EYPT | 338.47K | $4.84M |
COMPASS Pathways plc | CMPS | 284.77K | $4.03M |
Abivax S.A. | ABVX | 283.66K | $37.8M |
Immunovant, Inc. | IMVT | 276.53K | $10.65M |
Alkermes plc | ALKS | 248.01K | $12.99M |
Scholar Rock Holding Corporation | SRRK | 239.15K | $13.15M |